size) of the IMP
Sponsors
Antwerp University Hospital, Acousia Therapeutics GmbH
Conditions
Progressive Multiple Sclerosissensorineural hearing loss (SNHL)
Phase 2
Metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration: a phase IIb triple-blind placebo-controlled randomized clinical trial (MACSiMiSE-BRAIN)
Active, not recruitingCTIS2023-503190-38-00
Start: 2023-11-23Target: 120Updated: 2025-11-07
Metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration: a phase IIb triple-blind placebo-controlled randomized clinical trial (MACSiMiSE-BRAIN)
Active, not recruitingCTIS2023-503190-38-00
Start: 2023-11-23Target: 120Updated: 2025-11-07
Phase IIa randomized, double-blind, and placebo-controlled multicenter split body trial to determine safety, tolerability, and efficacy of repeated doses of ACOU085 for the prevention of hearing loss in testicular cancer patients receiving cisplatin
Active, not recruitingCTIS2023-503696-15-00
Start: 2023-11-10Target: 40Updated: 2025-12-15